Kerri Clifton

Kerri Clifton has a diverse work experience in the field of quality assurance and management. Kerri currently holds the position of Director of Quality Assurance at Perspective Therapeutics since May 2023. Prior to that, they worked as a Radiopharmaceutical Quality Assurance Manager at Viewpoint Molecular Targeting, Inc. from August 2021 to May 2023. Kerri also worked as a Product Stewardship & Quality Manager at Magris Talc USA, Inc. from February 2021 to September 2021.

From 2018 to 2021, Kerri Clifton worked at Imerys, starting as a Quality Project Manager from April 2018 to December 2018, and then transitioning to the role of Regional Quality Manager at Talc North America from 2019 to February 2021. Before joining Imerys, they served as a QA Manager at Mesa Laboratories, Inc. from October 2016 to March 2018.

Kerri Clifton began their career at Southern Isotopes, where they worked as a Quality Control Manager from July 2002 to August 2014. Prior to that, they gained experience as a QA Specialist at Takeda Pharmaceuticals from August 2014 to October 2016.

Kerri Clifton obtained a Bachelor of Science degree in Chemistry from Louisiana State University, where they studied from 1997 to 2001.